Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aluminum and renal osteodystrophy.

D J Sherrard

    Seminars in Nephrology
    |December 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Distinguishing between hyperparathyroidism and aluminum bone disease in dialysis patients is crucial. Early diagnosis prevents misdiagnosis, which can worsen aluminum toxicity and impact patient outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Response to 'The low-calcium concentration of dialysate induced a marked increase of serum parathyroid hormone level in a continuous ambulatory peritoneal dialysis patient'.

    Kidney international·2007
    Same author

    Reversal of adynamic bone disease by lowering of dialysate calcium.

    Kidney international·2006
    Same author

    Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study.

    Journal of vascular surgery·2001
    Same author

    Assessment of a policy to reduce placement of prosthetic hemodialysis access.

    Kidney international·2001
    Same author

    Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2001
    Same author

    Risk factors for hip fracture among patients with end-stage renal disease.

    Kidney international·2000
    Same journal

    Current Options for Kidney Protection: Are Renin-Angiotensin System Inhibitors Still Relevant?

    Seminars in nephrology·2026
    Same journal

    Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity.

    Seminars in nephrology·2026
    Same journal

    Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?

    Seminars in nephrology·2026
    Same journal

    From Nephron Number to Global Health.

    Seminars in nephrology·2026
    Same journal

    Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.

    Seminars in nephrology·2026
    Same journal

    Of Diuretics, Transporters, and Mechanisms of Hypertension.

    Seminars in nephrology·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Bone Metabolism
    • Toxicology

    Background:

    • Bone disease is a significant complication in dialysis patients.
    • Hyperparathyroidism was initially considered the primary cause, but aluminum toxicity is now recognized.
    • Differentiating these conditions is challenging due to overlapping clinical and laboratory features.

    Purpose of the Study:

    • To elucidate the distinctions between aluminum bone disease and renal osteodystrophy in dialysis patients.
    • To highlight the importance of accurate diagnosis to prevent mismanagement.
    • To guide clinicians in differentiating these bone abnormalities.

    Main Methods:

    • Comparison of clinical and laboratory features of hyperparathyroidism and aluminum toxicity.
    • Analysis of bone histology and formation rates.

    Related Experiment Videos

  • Measurement of serum aluminum levels and use of deferoxamine challenge test.
  • Consideration of bone biopsy when noninvasive methods are inconclusive.

    • Main Results:

    • Hyperparathyroidism shows increased osteoid, high bone formation, and low serum aluminum.
    • Aluminum toxicity is characterized by low bone turnover, reduced bone cells, and significant aluminum deposition.
    • Serum aluminum levels and deferoxamine challenge tests are key diagnostic tools.

    Conclusions:

    • Accurate differentiation between hyperparathyroidism and aluminum bone disease is essential for appropriate patient management.
    • Misdiagnosis can lead to parathyroidectomy, potentially worsening aluminum toxicity.
    • Understanding the distinct histopathological and biochemical profiles aids in diagnosis.